[On the treatment of myasthenia].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000549:Ambenonium Chloride / Q000627:therapeutic use*; D004576:Electromyography; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000503:physiopathology; D009388:Neostigmine / Q000627:therapeutic use*; D011729:Pyridostigmine Bromide / Q000627:therapeutic use*; D009435:Synaptic Transmission; D013934:Thymectomy
D007166:Immunosuppressive Agents; D009388:Neostigmine; D000549:Ambenonium Chloride; D000324:Adrenocorticotropic Hormone; D011729:Pyridostigmine Bromide
Le traitement de la myasthénie.